Amanda Schalk

Title: Amanda Schalk: Innovator in Cancer Treatment

Introduction

Amanda Schalk is a notable inventor based in Chicago, IL (US). She has made significant contributions to the field of cancer treatment through her innovative work on L-asparaginase variants. Her research focuses on developing truncated and humanized forms of guinea pig L-asparaginase, which have potential applications in treating various types of leukemia.

Latest Patents

Amanda Schalk holds 1 patent for her invention titled "Truncated guinea pig L-asparaginase variants and methods of use." This patent describes the development of variant guinea pig L-asparaginases that are truncated and humanized. These variants, along with fusion proteins containing the L-asparaginase, are utilized in the treatment of cancers such as acute lymphoblastic leukemia and acute myeloid leukemia.

Career Highlights

Throughout her career, Amanda has worked with prestigious institutions, including the University of Illinois and the United States Government as represented by the Department of Veterans Affairs. Her work has been instrumental in advancing cancer treatment methodologies and improving patient outcomes.

Collaborations

Amanda has collaborated with esteemed colleagues, including Arnon Lavie and Hien-Anh Nguyen. These partnerships have contributed to her innovative research and the successful development of her patented technologies.

Conclusion

Amanda Schalk is a pioneering inventor whose work in developing L-asparaginase variants is making a significant impact in the field of cancer treatment. Her contributions are paving the way for new therapeutic approaches to combat leukemia.